On January 4, 2021, Checkmate Pharmaceuticals, Inc. appointed Robert Dolski as the company’s principal financial officer and principal accounting officer. Prior to joining the Company, Mr. Dolski served as Vice President, Finance, for Akcea Therapeutics, Inc. From June 2016 to May 2019, Mr. Dolski was Vice President, Head of Financial Planning and Analysis at Moderna, Inc. and from December 2013 to June 2016, Mr. Dolski was Senior Director, Finance at Forum Pharmaceuticals Inc.